ArTS Archivio della ricerca di Trieste

SBLATTERO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.500
EU - Europa 19.513
AS - Asia 17.921
SA - Sud America 5.507
AF - Africa 655
OC - Oceania 403
Continente sconosciuto - Info sul continente non disponibili 34
Totale 74.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.426
CN - Cina 6.058
IT - Italia 5.190
BR - Brasile 3.332
SG - Singapore 2.618
DE - Germania 1.724
PL - Polonia 1.683
ES - Italia 1.607
MX - Messico 1.300
GB - Regno Unito 1.269
FR - Francia 1.216
JP - Giappone 1.187
TR - Turchia 1.184
IN - India 1.138
SE - Svezia 1.134
VN - Vietnam 1.080
HK - Hong Kong 971
UA - Ucraina 857
ID - Indonesia 779
KR - Corea 694
FI - Finlandia 591
NL - Olanda 586
CA - Canada 531
CO - Colombia 500
AR - Argentina 490
PT - Portogallo 479
RU - Federazione Russa 479
TW - Taiwan 450
PE - Perù 390
GR - Grecia 353
CL - Cile 352
AU - Australia 337
AT - Austria 285
CH - Svizzera 262
TH - Thailandia 259
IE - Irlanda 257
BE - Belgio 235
EC - Ecuador 235
RO - Romania 206
BG - Bulgaria 196
SA - Arabia Saudita 191
PK - Pakistan 175
DK - Danimarca 166
EG - Egitto 152
IR - Iran 142
IL - Israele 118
CZ - Repubblica Ceca 111
MA - Marocco 110
HU - Ungheria 106
MY - Malesia 101
PH - Filippine 94
IQ - Iraq 91
BD - Bangladesh 90
ZA - Sudafrica 87
HR - Croazia 84
VE - Venezuela 78
SI - Slovenia 71
RS - Serbia 69
NZ - Nuova Zelanda 63
TN - Tunisia 63
LB - Libano 54
LT - Lituania 54
NO - Norvegia 54
LV - Lettonia 51
JO - Giordania 47
PA - Panama 47
AE - Emirati Arabi Uniti 46
KZ - Kazakistan 43
UY - Uruguay 42
BO - Bolivia 40
CR - Costa Rica 40
PY - Paraguay 40
GT - Guatemala 38
SK - Slovacchia (Repubblica Slovacca) 36
UZ - Uzbekistan 36
DZ - Algeria 35
NG - Nigeria 32
HN - Honduras 27
QA - Qatar 27
NP - Nepal 26
PS - Palestinian Territory 26
LK - Sri Lanka 25
KE - Kenya 24
DO - Repubblica Dominicana 22
SY - Repubblica araba siriana 22
EU - Europa 20
OM - Oman 20
BY - Bielorussia 19
CY - Cipro 19
EE - Estonia 18
ET - Etiopia 18
AZ - Azerbaigian 17
SN - Senegal 16
GE - Georgia 15
NI - Nicaragua 14
KW - Kuwait 13
MD - Moldavia 13
BA - Bosnia-Erzegovina 12
LY - Libia 12
SV - El Salvador 12
Totale 74.254
Salva come PNG Salva come JPEG
Città #
Ashburn 9.678
Singapore 1.611
Woodbridge 1.543
Fairfield 1.441
Houston 1.431
Ann Arbor 1.386
Warsaw 1.153
Germantown 1.013
Chandler 935
San Jose 793
Beijing 758
Jacksonville 743
Wilmington 691
Hong Kong 677
Seattle 677
Milan 665
Trieste 581
São Paulo 546
Rome 536
Cambridge 517
Seoul 442
Madrid 413
Dallas 401
Hefei 377
Shanghai 375
Ho Chi Minh City 363
Guangzhou 353
Munich 351
Chicago 335
Tokyo 329
Los Angeles 328
Princeton 315
Istanbul 306
Izmir 306
Boardman 281
Hanoi 277
Frankfurt am Main 257
Lima 252
Rio de Janeiro 252
Barcelona 250
Paris 247
Dublin 237
New York 233
Helsinki 225
Bogotá 215
Hangzhou 214
Moscow 194
The Dalles 191
Columbus 186
Athens 185
Buenos Aires 182
Santiago 182
Taipei 179
Sofia 176
Jakarta 174
Lisbon 171
Ankara 167
Vienna 166
Lauterbourg 153
Zgierz 152
Naples 150
Chengdu 149
Amsterdam 146
Turin 141
Bangkok 138
Bengaluru 138
Bologna 138
London 137
Florence 131
Nanjing 129
Buffalo 124
Curitiba 121
Chennai 117
Brasília 116
Mumbai 109
Medellín 106
Hyderabad 105
Berlin 104
Santa Clara 104
Council Bluffs 102
Melbourne 101
Washington 101
Zurich 100
Brussels 99
Las Vegas 99
Jinan 98
Valencia 98
Toronto 95
Wuhan 95
Quito 94
San Diego 94
Porto Alegre 93
Sydney 93
Belo Horizonte 91
Montreal 91
Guadalajara 90
Porto 90
Copenhagen 89
Goiânia 88
Boston 87
Totale 42.158
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.755
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 436
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 407
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 349
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 341
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 338
Rational design of antirheumatic prodrugs specific for sites of inflammation 327
Anti-transglutaminase antibodies and age. 303
Anti transglutaminase antibodies cause ataxia in mice. 297
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 297
A reliable screening procedure for coeliac disease in clinical practice. 294
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 288
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 285
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 278
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 277
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 265
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 261
Phage display technology for human monoclonal antibodies 259
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 257
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 252
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 250
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 247
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 241
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 241
An Air-well sparging minifermenter system for high-throughput protein production 240
Recombinant antibody selections by combining phage and yeast display 240
Autoantibodies as predictors of disease. 239
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 238
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 235
The gut as site of production of autoimmune antibodies. 233
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 231
Clinical Presentation in Children With Coeliac Disease in Central Europe 230
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 230
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 229
Dual sugar gut-permeability testing on blood drop in animal models. 229
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 228
A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties 228
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 225
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 221
Primer sets for cloning the human repertoire of T cell Receptor variable regions 221
A deep-blue OLED-based biochip for protein microarray fluorescence detection 221
A definitive set of oligonucleotide primers for amplifying human V regions 218
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 215
Anti-idiotypic response in mice expressing human autoantibodies. 211
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 210
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 209
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 209
Anti-alpha enolase autoantibodies in coeliac disease 208
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 208
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 207
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 207
Antibodies in proteomics I: generating antibodies 204
Antibodies to transglutaminasefrom phage display libraries 203
Development of a novel rapid non-invasive screening test for coeliac disease. 201
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 199
Recombinant renewable polyclonal antibodies 198
Gluten ataxia: passive transfer in a mouse model. 196
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 195
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 195
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 194
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 194
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 193
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 193
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 192
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 192
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 190
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 185
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 184
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 183
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 182
Protective role of anti-idiotypic network in celiac disease prone subjects 181
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 179
Management of coeliac disease patients after the confirmation of diagnosis in Central Europe 178
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 177
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 177
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 177
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 174
Prevalence of celiac disease among risk groups and the general population in USA 174
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 174
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 172
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 171
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 169
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 169
Plasmid incompatibility: More compatible than previously thought? 169
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 169
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 167
Protective role of anti-idiotypic network in celiac disease prone subjects 167
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 167
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 167
null 166
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 165
Proteomic studies of the biofilm matrix including outer membrane vesicles of burkholderia multivorans c1576, a strain of clinical importance for cystic fibrosis 165
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 164
null 163
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 162
Selection and characterization of highly specific recombinant antibodies against West Nile Virus E protein 161
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 160
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 156
Protective role of anti-idiotypic network in celiac disease prone subjects 156
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 156
Totale 66.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 0 0 0 0 0 104 245
2021/20221.699 86 114 68 138 65 155 74 55 206 177 139 422
2022/20232.648 253 328 213 379 265 483 26 238 285 25 115 38
2023/20241.458 80 78 72 93 154 192 222 271 22 36 132 106
2024/202522.129 40 159 256 319 376 440 241 242 523 417 6.047 13.069
2025/202634.480 5.986 5.063 5.919 5.547 5.332 2.576 1.225 342 1.027 1.238 225 0
Totale 75.043